Matthew Gagné

4.1k total citations · 1 hit paper
20 papers, 449 citations indexed

About

Matthew Gagné is a scholar working on Infectious Diseases, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Matthew Gagné has authored 20 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Matthew Gagné's work include Effects and risks of endocrine disrupting chemicals (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and HIV Research and Treatment (3 papers). Matthew Gagné is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and HIV Research and Treatment (3 papers). Matthew Gagné collaborates with scholars based in United States, Canada and France. Matthew Gagné's co-authors include Daniel C. Douek, Mark G. Lewis, Daniel Harari, Eyal Zoler, Robert A. Seder, Shir Marciano, Jeanne Chiaravalli, Chunlin Li, Bjoern Meyer and Orly Dym and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Matthew Gagné

19 papers receiving 444 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

2021 230 citations Jiří Zahradník, Shir Marciano et al. Nature Microbiology profile →

Peers

Countries citing papers authored by Matthew Gagné

Since Specialization

Citations

This map shows the geographic impact of Matthew Gagné's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Gagné with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Gagné more than expected).

Fields of papers citing papers by Matthew Gagné

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Gagné. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Gagné. The network helps show where Matthew Gagné may publish in the future.

Co-authorship network of co-authors of Matthew Gagné

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Gagné. A scholar is included among the top collaborators of Matthew Gagné based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Gagné. Matthew Gagné is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integration of new approach methods for the assessment of data-poor chemicals 2025 ·Toxicological Sciences ·Katie Paul Friedman, Russell S. Thomas, John F. Wambaugh, Joshua Harrill, Richard Judson, Timothy J. Shafer, Antony Williams, (unknown), Lit‐Hsin Loo, Matthew Gagné, Alexandra S. Long, Tara S. Barton‐Maclaren, (unknown), Mounir Bouhifd, M.M.M. Rasenberg, Ulla Simanainen, Tomasz Sobański	8
2	Immunological duet between CD4+ T cells and B cells in the lung following an intranasal protein boost 2025 ·Nature Immunology ·Matthew Gagné, Daniel C. Douek, Robert A. Seder	0
3	Development and application of consensus in silico models for advancing high-throughput toxicological predictions 2024 ·Frontiers in Pharmacology ·Sean P. Collins, (unknown), Sunil Kulkarni, Matthew Gagné, Alexandra S. Long, Tara S. Barton‐Maclaren	7
4	High-throughput transcriptomics toxicity assessment of eleven data-poor bisphenol A alternatives 2024 ·Environmental Pollution ·Marc A. Beal, (unknown), (unknown), Matthew Gagné, Tara S. Barton‐Maclaren, (unknown), Andrea Rowan‐Carroll, Andrew Williams, Matthew J. Meier	3
5	Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans 2024 ·Cell Reports ·Kalani Ratnasiri, Hong Zheng, (unknown), Zhiyuan Yao, Verónica Durán, Michele Donato, Mario Roederer, Megha Kamath, John-Paul Todd, Matthew Gagné, Kathryn E. Foulds, Joseph R. Francica, Kizzmekia S. Corbett, Daniel C. Douek, Robert A. Seder, Shirit Einav, Catherine A. Blish, Purvesh Khatri	1
6	Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines 2024 ·Nature ·Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu, Yuhao Li, Guha Asthagiri Arunkumar, James Brett Case, Suzanne M. Scheaffer, Seth J. Zost, (unknown), Matthew Gagné, Shayne F. Andrew, (unknown), Kathryn E. Foulds, Jason S. McLellan, James E. Crowe, Daniel C. Douek, Sean P. J. Whelan, Sayda M. Elbashir, Darin K. Edwards, Michael Diamond	25
7	From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis 2023 ·Communications Biology ·Ohad Yogev, Omer Weissbrod, Giorgia Battistoni, Dario Bressan, Adi Naamati, Ilaria Falciatori, (unknown), (unknown), Rhys Izuagbe, Myra Hosmillo, (unknown), (unknown), Lauren McCormick, Christopher Cole Honeycutt, Timothy S. Johnston, Matthew Gagné, Daniel C. Douek, Ian Goodfellow, Gregory J. Hannon, Yaniv Erlich	6
8	In vitrotranscriptomic analyses reveal pathway perturbations, estrogenic activities, and potencies of data-poor BPA alternative chemicals 2022 ·Toxicological Sciences ·(unknown), Karen Leingartner, Andrea Rowan‐Carroll, Matthew J. Meier, Andrew Williams, Marc A. Beal, Matthew Gagné, Reza Farmahin, (unknown), Anthony Reardon, Tara S. Barton‐Maclaren, J. Christopher Corton, Carole L. Yauk, Ella Atlas	23
9	Rapid Detection and Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Variant in a Returning Traveler 2022 ·Clinical Infectious Diseases ·(unknown), Jesse J. Waggoner, (unknown), (unknown), (unknown), (unknown), (unknown), Robert A. Arthur, Mit Patel, (unknown), Stephanie L. Foster, Kathryn M. Moore, Matthew Gagné, Jesmine Roberts-Torres, Amy R. Henry, Sucheta Godbole, Daniel C. Douek, Nadine Rouphael, Mehul S. Suthar, Anne Piantadosi	6
10	Canadian Regulatory Perspective on Next Generation Risk Assessments for Pest Control Products and Industrial Chemicals 2021 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Marc A. Beal, Sunil Kulkarni, Matthew Gagné, Tara S. Barton‐Maclaren	24
11	SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution breakdown → 2021 ·Nature Microbiology ·Jiří Zahradník, Shir Marciano, Maya Shemesh, Eyal Zoler, Daniel Harari, Jeanne Chiaravalli, Bjoern Meyer, Yinon Rudich, Chunlin Li, Ira Marton, Orly Dym, Nadav Elad, Mark G. Lewis, Hanné Andersen, Matthew Gagné, Robert A. Seder, Daniel C. Douek, Gideon Schreiber	230
12	Open Characterization of Vaping Liquids in Canada: Chemical Profiles and Trends 2021 ·Frontiers in Chemistry ·Ivana Kosarac, Cariton Kubwabo, Xinghua Fan, Shabana Siddique, (unknown), Wei He, J. C. de Man, Matthew Gagné, (unknown), T. Mischki	4
13	Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9 2020 ·Viruses ·Alex Olson, (unknown), Seunghee Lee, Matthew Gagné, Wilson W. Wong, Andrew J. Henderson	21
14	Strength of T cell signaling regulates HIV-1 replication and establishment of latency 2019 ·PLoS Pathogens ·Matthew Gagné, (unknown), Gillian M. Schiralli Lester, Suryaram Gummuluru, Wilson W. Wong, Andrew J. Henderson	17
15	Predicting estrogen receptor activation by a group of substituted phenols: An integrated approach to testing and assessment case study 2019 ·Regulatory Toxicology and Pharmacology ·(unknown), Matthew Gagné, Grace Patlewicz, Prachi Pradeep, (unknown), Richard Judson, Tara S. Barton‐Maclaren	23
16	Impact of Chromatin on HIV Replication 2015 ·Genes ·Luis M. Agosto, Matthew Gagné, Andrew J. Henderson	19
17	Investigation of intrathecal transport of NPT002, a prospective therapeutic based on phage M13, in nonhuman primates 2012 ·Drug Delivery and Translational Research ·Mikhail Papisov, Vasily Belov, (unknown), Alan J. Fischman, Rory A. Fisher, Jason Wright, K.S. Gannon, James S. Titus, Matthew Gagné, (unknown)	8
18	Delivery of proteins to CNS as seen and measured by positron emission tomography 2012 ·Drug Delivery and Translational Research ·Mikhail Papisov, Vasily Belov, Alan J. Fischman, (unknown), James S. Titus, Matthew Gagné, (unknown)	17
19	[Reiter's syndrome in children]. 1983 ·PubMed ·Matthew Gagné, (unknown), (unknown), Marek Rola‐Pleszczynski, (unknown)	3
20	[Whipple's disease without digestive manifestations: late-diagnosis arthropathy]. 1983 ·PubMed ·Matthew Gagné, June M. Brown, A Lussier, Marek Rola‐Pleszczynski, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact